对我国优先审评审批罕见病用药特征的思考

陈倩楠, 刘晓溪, 连桂玉, 黄哲

Thoughts on the characteristics of priority review and approval of rare disease drugs in China

CHEN Qian-nan, LIU Xiao-xi, LIAN Gui-yu, HUANG Zhe

中国新药杂志 . 2026, (13): 1352 -1357 . DOI: 10.20251/j.cnki.1003-3734.2026.13.002